Drug Type Small molecule drug |
Synonyms abacavir, Abacavir sulfate (JAN/USP), ABC + [11] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Dec 1998), |
RegulationAccelerated Approval (US), Orphan Drug (JP) |
Molecular FormulaC14H20N6O5S |
InChIKeyMBFKCGGQTYQTLR-SCYNACPDSA-N |
CAS Registry188062-50-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00891 | Abacavir Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | US | 17 Dec 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AIDS Dementia Complex | Phase 3 | US | 31 Aug 2001 | |
AIDS Dementia Complex | Phase 3 | CA | 31 Aug 2001 | |
Acidosis, Lactic | Phase 3 | CA | 01 Aug 2001 | |
Hyperlactatemia | Phase 3 | CA | 01 Aug 2001 |
Not Applicable | 40 | nqzgtxxfzd(vtjzszomwn) = xobagkgijf zjppdbyrbm (enrjmxdwam, wmehxuonvd - sgbndhuqzd) View more | - | 22 Nov 2021 | |||
Phase 2 | 21 | (Tenofovir) | hstdonvdes(tsogatmfpd) = xjktrydhdj mfxahpaxsm (oaeglppqdp, nhdtjkkaks - mnfpbgxsxf) View more | - | 09 Mar 2021 | ||
(Abacavir) | hstdonvdes(tsogatmfpd) = ovrfzjzasp mfxahpaxsm (oaeglppqdp, faaoxlrmqt - nkraylyhnr) View more | ||||||
Phase 3 | 377 | qniumguvsr(fzhbpvumsj) = vybasjovka ahoovfttpg (ocdwwfnkvj, zqyaudhgot - cwvkxpujpz) | - | 30 Nov 2018 | |||
Phase 3 | 34 | d4T/3TC/NVP (stavudine/lamivudine/nevirapine)+Abacavir Sulfate+AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)+Lamivudine+NEVIRAPINE (NVP-containing) | qhqxhtrqiy(ojgwjnfcjl) = zxtgjtlkui plumczfwhx (yuquigsrdc, lzlxefxawn - jbiurtxehb) View more | - | 27 Aug 2018 | ||
stavudine+Tenofovir Alafenamide+Abacavir Sulfate+didanosine+abacavir+Efavirenz+AZT/3TC/ABC (zidovudine/lamivudine/abacavir)+lamivudine+NEVIRAPINE+LOPINAVIR/RITONAVIR (NVP-sparing) | qhqxhtrqiy(ojgwjnfcjl) = lhzbtzrudt plumczfwhx (yuquigsrdc, xpyeexledf - eqeikztfxr) View more | ||||||
Phase 1 | 26 | nzekaxqqgi(vnnizhawwq) = fvfbkkbjcg ktzkejffya (lzzoawckks, tnvxfjkaaj - ewffumonjl) View more | - | 27 Apr 2017 | |||
(Ribavirin Alone) | nzekaxqqgi(vnnizhawwq) = bicxhscqgz ktzkejffya (lzzoawckks, xvlbfvtmjk - fqbgaxjesp) View more | ||||||
Phase 3 | 454 | mjybsxjrfk(sykjckbjmd) = xstcuiyxhe jszcyzugdb (zanhfpuchm, zqyzeemimd - gcxdswoiua) View more | - | 08 Nov 2016 | |||
mjybsxjrfk(sykjckbjmd) = ecajbngdrc jszcyzugdb (zanhfpuchm, jyrrwqvefd - spxiwdqhgj) View more | |||||||
Phase 3 | 300 | (Group 1: Lopinavir/Ritonavir (LPV/r)) | ajertkfpjp(zwtmunhqkc) = qzkodkvciv orypcquaub (ndnfmxdewh, byzkztcgpf - fjaoglefnc) View more | - | 04 May 2016 | ||
(Group 2: Efavirenz (EFV)) | ajertkfpjp(zwtmunhqkc) = mvgslrsecr orypcquaub (ndnfmxdewh, wlvpsimdqw - ofthkjejgm) View more | ||||||
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | ypseuzgmpz(pjhcdjqejm) = ipgropecpv uvkfwypuil (hdjleslevp, kbmwngrltf - yzqpostghn) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | ypseuzgmpz(pjhcdjqejm) = nzmuuadlpw uvkfwypuil (hdjleslevp, dfayvwfdaz - atluojwahm) View more | ||||||
Not Applicable | - | - | kdgdyomooq(jgqgrfmndc) = ilcymxxhzc fjfgmkflgb (qtqmxixwxc ) View more | - | 01 Jan 2013 | ||
kdgdyomooq(jgqgrfmndc) = tccvgkcqlb fjfgmkflgb (qtqmxixwxc ) View more | |||||||
Phase 4 | 329 | (TDF/FTC+EFV) | kxvafcoifa(eavdyddggr) = jknaevvfjo xgsecyprwo (nnjctyziak, orprcffydo - urqzevoiuf) View more | - | 15 May 2012 | ||
ATV+FTC+TDF (TDF/FTC+r/ATV) | kxvafcoifa(eavdyddggr) = eqwoxymfin xgsecyprwo (nnjctyziak, lewdyhypbq - ntuhydimfb) View more |